TruBridge (NASDAQ:TBRG) Price Target Raised to $29.00

TruBridge (NASDAQ:TBRGFree Report) had its target price raised by Cantor Fitzgerald from $20.00 to $29.00 in a research report released on Tuesday,Benzinga reports. They currently have an overweight rating on the stock.

A number of other analysts have also issued reports on the stock. Stephens boosted their price target on shares of TruBridge from $13.00 to $17.00 and gave the stock an “equal weight” rating in a research note on Wednesday, November 20th. Barclays upped their target price on shares of TruBridge from $10.00 to $14.00 and gave the stock an “equal weight” rating in a research note on Monday, November 11th.

Check Out Our Latest Report on TruBridge

TruBridge Stock Down 3.8 %

Shares of NASDAQ:TBRG opened at $27.42 on Tuesday. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.80 and a quick ratio of 1.78. The firm has a market capitalization of $409.24 million, a PE ratio of -6.70, a price-to-earnings-growth ratio of 5.38 and a beta of 0.71. The firm’s 50-day moving average is $25.45 and its two-hundred day moving average is $18.41. TruBridge has a 1 year low of $7.61 and a 1 year high of $32.00.

Insider Activity at TruBridge

In other TruBridge news, major shareholder Pinetree Capital Ltd. purchased 74,981 shares of the stock in a transaction that occurred on Thursday, February 13th. The stock was purchased at an average cost of $27.61 per share, with a total value of $2,070,225.41. Following the completion of the acquisition, the insider now directly owns 693,981 shares of the company’s stock, valued at $19,160,815.41. This trade represents a 12.11 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders acquired 116,728 shares of company stock valued at $3,239,879 over the last three months. 3.60% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On TruBridge

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Hotchkis & Wiley Capital Management LLC acquired a new stake in shares of TruBridge in the third quarter valued at approximately $5,934,000. Federated Hermes Inc. boosted its holdings in shares of TruBridge by 3.1% in the fourth quarter. Federated Hermes Inc. now owns 468,758 shares of the company’s stock valued at $9,244,000 after acquiring an additional 14,120 shares during the period. Dimensional Fund Advisors LP boosted its holdings in shares of TruBridge by 12.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 348,941 shares of the company’s stock valued at $6,881,000 after acquiring an additional 38,902 shares during the period. Truffle Hound Capital LLC acquired a new stake in shares of TruBridge during the fourth quarter worth $5,916,000. Finally, D. E. Shaw & Co. Inc. lifted its holdings in shares of TruBridge by 8.4% during the fourth quarter. D. E. Shaw & Co. Inc. now owns 217,539 shares of the company’s stock worth $4,290,000 after purchasing an additional 16,821 shares during the period. 88.64% of the stock is owned by institutional investors and hedge funds.

About TruBridge

(Get Free Report)

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.

Further Reading

Receive News & Ratings for TruBridge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TruBridge and related companies with MarketBeat.com's FREE daily email newsletter.